Published in Eur J Pharmacol on July 23, 1991
Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol (1994) 1.09
Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice. Am J Physiol Heart Circ Physiol (2011) 0.87
Release of endothelium-derived hyperpolarizing factor (EDHF) by M3 receptor stimulation in guinea-pig coronary artery. Br J Pharmacol (1995) 0.84
Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries. Br J Pharmacol (1993) 0.82
Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins. Br J Pharmacol (2000) 0.76
Vitamin C Deficiency Reduces Muscarinic Receptor Coronary Artery Vasoconstriction and Plasma Tetrahydrobiopterin Concentration in Guinea Pigs. Nutrients (2017) 0.75
Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.95
Coassembly of Trp1 and Trp3 proteins generates diacylglycerol- and Ca2+-sensitive cation channels. J Biol Chem (2000) 1.81
Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers. J Clin Invest (1982) 1.54
Current modulation and membrane targeting of the calcium channel alpha1C subunit are independent functions of the beta subunit. J Physiol (1999) 1.45
Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem J (1992) 1.23
Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J Cardiovasc Pharmacol (1994) 1.21
Intracellular Ca2+ inhibits smooth muscle L-type Ca2+ channels by activation of protein phosphatase type 2B and by direct interaction with the channel. J Gen Physiol (1997) 1.21
Activation of a small-conductance Ca(2+)-dependent K+ channel contributes to bradykinin-induced stimulation of nitric oxide synthesis in pig aortic endothelial cells. Biochim Biophys Acta (1992) 1.20
Release of nitric oxide from donors with known half-life: a mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.19
Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways. Br J Pharmacol (2012) 1.14
Assay of phosphodiesterase with radioactively labeled cyclic 3',5'-AMP as substrate. Naunyn Schmiedebergs Arch Pharmakol (1971) 1.14
Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves. J Pharmacol Methods (1980) 1.11
Na(+)/Ca(2+) exchange facilitates Ca(2+)-dependent activation of endothelial nitric-oxide synthase. J Biol Chem (1999) 1.09
Role of cyclic nucleotides in adenosine-mediated regulation of coronary flow. Adv Cyclic Nucleotide Res (1978) 1.09
Distinct Ca(2+)-permeable cation currents are activated by internal Ca(2+)-store depletion in RBL-2H3 cells and human salivary gland cells, HSG and HSY. J Membr Biol (2004) 1.08
The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery. Br J Pharmacol (1994) 1.08
Phospholipase C-dependent control of cardiac calcium homeostasis involves a TRPC3-NCX1 signaling complex. Cardiovasc Res (2006) 1.08
Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF). Biochem J (1992) 1.07
High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes (1996) 1.03
Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells. Eur J Pharmacol (1989) 1.03
Cyclic AMP enhances agonist-induced Ca2+ entry into endothelial cells by activation of potassium channels and membrane hyperpolarization. Biochem J (1993) 1.03
SK&F 96365 inhibits histamine-induced formation of endothelium-derived relaxing factor in human endothelial cells. Biochem Biophys Res Commun (1992) 1.03
The positive inotropic effect of cyclic AMP. Adv Cyclic Nucleotide Res (1972) 1.02
Effect of sodium fluoride on cytosolic free Ca2(+)-concentrations and cGMP-levels in endothelial cells. Cell Signal (1990) 1.02
Trypsin increases availability and open probability of cardiac L-type Ca2+ channels without affecting inactivation induced by Ca2+. Biophys J (1995) 1.01
Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues. Life Sci I (1971) 1.00
Drug-induced release and pharmacodynamic effects of histamine in the guinea-pig heart. J Pharmacol Exp Ther (1967) 1.00
Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. Atherosclerosis (1982) 1.00
Time dependence in mixture toxicity with soft electrophiles: 1. Combined effects of selected SN2- and SNAr-reactive agents with a nonpolar narcotic. Arch Environ Contam Toxicol (2007) 1.00
Protein kinase-C mediates dual modulation of L-type Ca2+ channels in human vascular smooth muscle. FEBS Lett (1994) 1.00
Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.99
Evidence for a role of Trp proteins in the oxidative stress-induced membrane conductances of porcine aortic endothelial cells. Cardiovasc Res (1999) 0.99
Mixture toxicity of SN2-reactive soft electrophiles: 1. Evaluation of mixtures containing α-halogenated acetonitriles. Arch Environ Contam Toxicol (2010) 0.98
Voltage-sensitive chloride channels of large conductance in the membrane of pig aortic endothelial cells. Pflugers Arch (1992) 0.97
Histamine induces K+, Ca2+, and Cl- currents in human vascular endothelial cells. Role of ionic currents in stimulation of nitric oxide biosynthesis. Circ Res (1994) 0.97
A sequence in the carboxy-terminus of the alpha(1C) subunit important for targeting, conductance and open probability of L-type Ca(2+) channels. FEBS Lett (2000) 0.95
Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions. Br J Pharmacol (1992) 0.95
The action of imidazole on the effects of methyl-xanthines and catecholamines on cardiac contraction and phosphorylase activity. J Pharmacol Exp Ther (1967) 0.95
Molecular mechanism of action of nicorandil. J Cardiovasc Pharmacol (1992) 0.95
Prostacyclin increases cAMP in coronary arteries. J Cyclic Nucleotide Res (1979) 0.94
Inhibition of a store-operated Ca2+ entry pathway in human endothelial cells by the isoquinoline derivative LOE 908. Br J Pharmacol (1996) 0.94
[Stimulation of adrenergic beta-receptors in the heart of normal and reserpinized guinea pigs by oxyfedrine]. Arzneimittelforschung (1969) 0.94
Intracellular Ca2+ inactivates L-type Ca2+ channels with a Hill coefficient of approximately 1 and an inhibition constant of approximately 4 microM by reducing channel's open probability. Biophys J (1997) 0.94
S-nitrosation controls gating and conductance of the alpha 1 subunit of class C L-type Ca(2+) channels. J Biol Chem (2001) 0.93
Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes (1993) 0.93
Quantitative relations between cyclic AMP and contraction as affected by stimulators of adenylate cyclase and inhibitors of phosphodiesterase. Adv Cyclic Nucleotide Res (1975) 0.92
Mixture toxicity of S(N)2-reactive soft electrophiles: 2-evaluation of mixtures containing ethyl α-halogenated acetates. Arch Environ Contam Toxicol (2011) 0.92
Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett (1995) 0.92
Mechanism of nitrate-induced vasodilation and tolerance. Z Kardiol (1983) 0.92
Mode of action of coronary arterial relaxation by prostacyclin. J Cyclic Nucleotide Res (1980) 0.91
Expression of Trp3 determines sensitivity of capacitative Ca2+ entry to nitric oxide and mitochondrial Ca2+ handling: evidence for a role of Trp3 as a subunit of capacitative Ca2+ entry channels. J Biol Chem (2001) 0.91
Comparison of neuronal and endothelial isoforms of nitric oxide synthase in stably transfected HEK 293 cells. Am J Physiol Heart Circ Physiol (2001) 0.90
Cardiostimulatory effects of cyclic 3',5'-adenosine monophosphate and its acylated derivatives. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.90
Radioligand binding to muscarinic receptors of bovine aortic endothelial cells. Br J Pharmacol (1991) 0.90
Estimating the number of channels in patch-clamp recordings: application to kinetic analysis of multichannel data from voltage-operated channels. Biophys J (1997) 0.89
Guanylate cyclase activation by organic nitrates is not mediated via nitrite. J Mol Cell Cardiol (1988) 0.89
Mode of action of nitrates with regard to vasodilatation and tolerance. Z Kardiol (1986) 0.89
Molecular determinant for run-down of L-type Ca2+ channels localized in the carboxyl terminus of the 1C subunit. J Physiol (2000) 0.88
Bradykinin-induced Ca(2+)-influx into cultured aortic endothelial cells is not regulated by inositol 1,4,5-trisphosphate or inositol 1,3,4,5-tetrakisphosphate. Second Messengers Phosphoproteins (1991) 0.88
Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry. Thromb Res (2001) 0.87
Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytes. Biochem Biophys Res Commun (1991) 0.87
Differentiation of intestinal smooth muscle relaxation caused by drugs that inhibit phosphodiesterase. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.87
Function of cyclic GMP in acetylcholine-induced contraction of coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.86
Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J Cardiovasc Pharmacol (1991) 0.86
Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart. Cardiovasc Res (1997) 0.86
ATP inhibits smooth muscle Ca2(+)-activated K+ channels. Proc Biol Sci (1990) 0.86
[Influence of cardio- and vasoactive substances on phosphodiesterase activity]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.86
Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial. Clin Cancer Res (1997) 0.85
TRPC3: a multifunctional, pore-forming signalling molecule. Handb Exp Pharmacol (2007) 0.85
Evidence for a direct inhibitory effect of extracellular H+ on store depletion-activated Ca2+ entry in vascular endothelial cells. Biochem Biophys Res Commun (1996) 0.85
Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies. Eur J Pharmacol (1991) 0.84
Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation. J Mol Cell Cardiol (1989) 0.84
Essential role of the beta subunit in modulation of C-class L-type Ca2+ channels by intracellular pH. FEBS Lett (1997) 0.83
Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation. Adv Cyclic Nucleotide Res (1972) 0.83
Effect of catecholamines, histamine and oxyfedrine on isotonic contraction and cyclic AMP in the guinea-pig heart. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.83